Liver transplatation-induced antihistone H1 autoantibodies suppress mixed lymphocyte reaction

Transplantation

Volumn 77, Issue 10, 2004, Pages 1595-1603

  Nakano, Toshiaki ^a   Kawamoto, Seiji ^a   Lai, Chia Yun ^b   Sasaki, Tetsuya ^c   Aki, Tsunehiro ^a   Shigeta, Seiko ^a   Goto, Takeshi ^d   Sato, Shuji ^d   Goto, Shigeru ^b,e   Chen, Chao Long ^b   Ono, Kazuhisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^d JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^e Iwao Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; HISTONE H1; IMMUNOGLOBULIN G; HISTONE; IMMUNOSUPPRESSIVE AGENT; MEMBRANE ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE MODEL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; SERUM; SPLEEN CELL; ANIMAL; CROSS REACTION; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; RAT STRAIN;

ANIMALS; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; CROSS REACTIONS; HISTONES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED STRAINS;

EID: 2542589311     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000123079.10650.71     Document Type: Article

References (30)

1. Rossini AA, Greiner DL, Mordes JP. Induction of immunologic tolerance for transplantation. Physiol Rev 1999; 79(1): 99.
2. Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity following orthotopic liver transplantation: A comparison between cyclosporine and FK506. Transplantation 1994; 58(2): 170.
3. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807.
4. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 377: 530.
5. Kobayashi E. Immunological tolerance induced by liver grafting: Cellular and humoral factors. Mol Med 1997; 34(7): 797.
6. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472,
7. Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981; 292: 840.
8. Kamada N, Brons G, Davies HS. Fully allogeneic liver grafting in rats induced a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29(5): 429.
9. Kamada N, Davies HS, Wight D, et al. Liver transplantation in the rat: Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation 1983; 35(4): 304.
10. Kamada N, Wight DG. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 38(3): 217.
11. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3(1): 51.
12. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999; 20(1): 27.
13. Kamada N, Shinomiya T, Tamaki T, et al. Immunosuppressive activity of serum from liver-grafted rats: Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance. Transplantation 1986; 42(6): 581.
14. Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 1990; 50(4): 678.
15. Tsurufuji M, Ishiguro K, Shinomiya T, et al. Immunosuppressive activity of serum from liver-grafted rats: In vitro specific inhibition of mixed lymphocyte reactivity by antibodies against class II RT1 alloantigens. Immunology 1987; 61: 421.
16. Lord R, Kamada N, Kobayashi E, et al. Isolation of a 40 kDa immunoin-hibitory protein induced by rat liver transplantation. Transpl Immunol 1995; 3: 174.
17. Edwards-Smith C, Goto S, Lord R, et al. Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats. Transpl Immunol 1996; 4: 287.
18. Goto S, Lord R, Kobayashi E, et al. Novel immunosuppressive proteins purified from the serum of liver-retransplanted rats. Transplantation 1996; 61(8): 1147.
19. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28(1): 47.
20. John EC, Ada MK, David HM, et al. Current protocols in immunology. New York, John Wiley & Sons 1994.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680.
22. Cole KD, Kandara JC, Kremer E, et al. Isolation of a genomic clone encoding the rat histone variant, H1d. Gene 1990; 89(2): 265.
23. Ohe Y, Hayashi H, Iwai K. Human spleen histone H1: Isolation and amino acid sequence of a main variant, H1b. J Biochem (Tokyo) 1986; 100(2):359.
24. Gioud M, Kaci MA, Monier JC. Histone antibodies in systemic lupus erythematosus: A possible diagnostic tool. Arthritis Rheum 1982; 25(4): 407.
25. Konikoff F, Swissa M, Shoenfeld Y. Autoantibodies to histones and their subfractions in chronic liver diseases. Clin Immunol Immunopathol 1989; 51(1): 77.
26. Meziere C, Stockl F, Batsford S, et al. Antibodies to DNA, chromatin core particles and histones in mice with graft-versus-host disease and their involvement in glomerular injury. Clin Exp Immunol 1994; 98: 287.
27. Mecheri S, Dannecker G, Dennig D, et al. Anti-histone autoantibodies react specifically with B cell surface. Mol Immunol 1993; 30(6): 549.
28. Raz E, Ben-Bassat H, Davidi T, et al. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur J Immunol 1993; 23: 383.
29. Kubota T, Kanai Y, Miyasaka N. Interpretation of the cross-reactivity of anti-DNA antibodies with cell surface proteins: The role of cell surface histones. Immunol Lett 1990; 23(3): 187.
30. Gabrilovich DI, Cheng P, Fan Y, et al. H1(O) histone and differentiation of dendritic cells: A molecular target for tumor-derived factors. J Leukoc Biol 2002; 72(2): 285.